These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 26674601)
1. Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis. Jiang Y; Li W; He X; Zhang H; Jiang F; Chen Z BMC Cancer; 2015 Dec; 15():948. PubMed ID: 26674601 [TBL] [Abstract][Full Text] [Related]
2. Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis. Jiang Y; Li W; He X; Zhang H; Jiang F; Chen Z BMC Cancer; 2016 Jan; 16():12. PubMed ID: 26758198 [TBL] [Abstract][Full Text] [Related]
3. LGR5, a relevant marker of cancer stem cells, indicates a poor prognosis in colorectal cancer patients: a meta-analysis. Han Y; Xue X; Jiang M; Guo X; Li P; Liu F; Yuan B; Shen Y; Guo X; Zhi Q; Zhao H Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):267-73. PubMed ID: 25193236 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of LGR5 in colorectal cancer: a meta-analysis. Chen Q; Zhang X; Li WM; Ji YQ; Cao HZ; Zheng P PLoS One; 2014; 9(9):e107013. PubMed ID: 25192390 [TBL] [Abstract][Full Text] [Related]
5. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer. Stanisavljević L; Myklebust MP; Leh S; Dahl O Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662 [TBL] [Abstract][Full Text] [Related]
6. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance. He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002 [TBL] [Abstract][Full Text] [Related]
7. Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis. Wu SW; Ma CC; Li WH Diagn Pathol; 2015 Aug; 10():144. PubMed ID: 26276145 [TBL] [Abstract][Full Text] [Related]
8. The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis. Wang J; Du S; Wang J; Fan W; Wang P; Zhang Z; Xu P; Tang S; Deng Q; Yang W; Yu M PLoS One; 2017; 12(6):e0179670. PubMed ID: 28658310 [TBL] [Abstract][Full Text] [Related]
9. High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis. Huang Q; Li S; Cheng P; Deng M; He X; Wang Z; Yang CH; Zhao XY; Huang J World J Gastroenterol; 2017 Jul; 23(27):5018-5033. PubMed ID: 28785155 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the adenocarcinoma-associated gene AGR2 and the intestinal stem cell marker LGR5 as biomarkers in colorectal cancer. Valladares-Ayerbes M; Blanco-Calvo M; Reboredo M; Lorenzo-Patiño MJ; Iglesias-Díaz P; Haz M; Díaz-Prado S; Medina V; Santamarina I; Pértega S; Figueroa A; Antón-Aparicio LM Int J Mol Sci; 2012; 13(4):4367-4387. PubMed ID: 22605983 [TBL] [Abstract][Full Text] [Related]
11. Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer. Gao FJ; Chen JY; Wu HY; Shi J; Chen M; Fan XS; Huang Q Int J Clin Exp Pathol; 2014; 7(4):1572-9. PubMed ID: 24817953 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients. Mirzaei A; Tavoosidana G; Modarressi MH; Rad AA; Fazeli MS; Shirkoohi R; Tavakoli-Yaraki M; Madjd Z Tumour Biol; 2015 Jun; 36(6):4801-10. PubMed ID: 25631749 [TBL] [Abstract][Full Text] [Related]
13. The impact of osteopontin on prognosis and clinicopathology of colorectal cancer patients: a systematic meta-analysis. Zhao M; Liang F; Zhang B; Yan W; Zhang J Sci Rep; 2015 Aug; 5():12713. PubMed ID: 26234583 [TBL] [Abstract][Full Text] [Related]
14. The prognostic value of leucine-rich repeat-containing G-protein (Lgr5) and its impact on clinicopathological features of colorectal cancer. Gzil A; Zarębska I; Jaworski D; Antosik P; Durślewicz J; Maciejewska J; Domanowska E; Skoczylas-Makowska N; Ahmadi N; Grzanka D; Szylberg Ł J Cancer Res Clin Oncol; 2020 Oct; 146(10):2547-2557. PubMed ID: 32671503 [TBL] [Abstract][Full Text] [Related]
15. Prognostic and clinicopathological value of MUC1 expression in colorectal cancer: A meta-analysis. Li C; Liu T; Yin L; Zuo D; Lin Y; Wang L Medicine (Baltimore); 2019 Mar; 98(9):e14659. PubMed ID: 30817589 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of MMP-7 expression in colorectal cancer: a meta-analysis. Sun DW; Zhang YY; Qi Y; Zhou XT; Lv GY Cancer Epidemiol; 2015 Apr; 39(2):135-42. PubMed ID: 25677090 [TBL] [Abstract][Full Text] [Related]
17. Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival. Wu XS; Xi HQ; Chen L World J Surg Oncol; 2012 Nov; 10():244. PubMed ID: 23153436 [TBL] [Abstract][Full Text] [Related]
18. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer. Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824 [TBL] [Abstract][Full Text] [Related]
19. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5. Sadek SA; A Rehim DM; Fatima S Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119 [TBL] [Abstract][Full Text] [Related]
20. The prognostic role of Leucine-rich repeat-containing G-protein-coupled receptor 5 in gastric cancer: A systematic review with meta-analysis. Huang T; Qiu X; Xiao J; Wang Q; Wang Y; Zhang Y; Bai D Clin Res Hepatol Gastroenterol; 2016 Apr; 40(2):246-53. PubMed ID: 26387842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]